2022 Q3 Form 10-K Financial Statement

#000121390022059811 Filed on September 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue $79.97K $122.5K $443.5K
YoY Change -30.13% -71.52% -36.75%
Cost Of Revenue $125.1K $126.4K $486.2K
YoY Change 0.2% -54.64% -32.64%
Gross Profit -$45.15K -$3.880K -$42.62K
YoY Change 333.3% -102.56% 107.6%
Gross Profit Margin -56.46% -3.17% -9.61%
Selling, General & Admin $126.3K $279.9K $492.7K
YoY Change -84.65% -78.17% -80.21%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $638.6K $279.9K $2.373M
YoY Change -22.43% -78.17% -4.67%
Operating Profit -$558.6K -$283.8K -$1.929M
YoY Change -33.0% -74.9% -23.12%
Interest Expense -$155.9K -$248.9K -$545.6K
YoY Change -125.9% 289.35%
% of Operating Profit
Other Income/Expense, Net -$544.6K $57.74K -$48.31K
YoY Change -96.48% -107.89%
Pretax Income -$1.201M -$474.9K -$2.523M
YoY Change 44.07% 1680.06% -27.49%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.201M -$474.9K -$2.523M
YoY Change 44.07% 1680.06% -27.49%
Net Earnings / Revenue -1501.95% -387.56% -568.9%
Basic Earnings Per Share -$0.01 -$0.03
Diluted Earnings Per Share -$0.01 -$6.137K -$0.03
COMMON SHARES
Basic Shares Outstanding 95.96M shares 87.52M shares
Diluted Shares Outstanding 92.71M shares 87.52M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $220.4K $280.9K $280.9K
YoY Change -53.27% -73.04% -73.04%
Cash & Equivalents $220.4K $280.9K
Short-Term Investments
Other Short-Term Assets $106.7K $137.8K $137.8K
YoY Change 184.73% 311.58% 311.59%
Inventory $433.2K $331.5K $331.5K
Prepaid Expenses
Receivables $130.4K $93.67K $93.67K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $890.7K $843.9K $843.9K
YoY Change -17.39% -46.34% -46.34%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $134.8K
YoY Change 302.62%
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $890.7K $843.9K $843.9K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $890.7K $843.9K $843.9K
YoY Change -17.39% -46.34% -46.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $434.4K $234.2K $234.2K
YoY Change 22.83% -49.06% -49.06%
Accrued Expenses $9.000K $0.00 $0.00
YoY Change -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $894.8K $344.2K $344.2K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.342M $578.3K $578.3K
YoY Change 279.5% 24.98% 24.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.342M $578.3K $578.3K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.342M $578.3K $578.3K
YoY Change 279.5% 24.98% 24.98%
SHAREHOLDERS EQUITY
Retained Earnings -$29.65M -$28.10M
YoY Change 11.53%
Common Stock $95.96K $91.81K
YoY Change 13.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$451.5K $265.6K $265.6K
YoY Change
Total Liabilities & Shareholders Equity $890.7K $843.9K $843.9K
YoY Change -17.39% -46.34% -46.34%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$1.201M -$474.9K -$2.523M
YoY Change 44.07% 1680.06% -27.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$414.6K -$341.2K -$2.070M
YoY Change -52.8% -43.02% 43.77%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $354.1K 99.98K $1.309M
YoY Change 14.91% -93.62% -42.69%
NET CHANGE
Cash From Operating Activities -$414.6K -341.2K -$2.070M
Cash From Investing Activities 0.000
Cash From Financing Activities $354.1K 99.98K $1.309M
Net Change In Cash -$60.47K -241.2K -$761.0K
YoY Change -124.9% -190.14%
FREE CASH FLOW
Cash From Operating Activities -$414.6K -$341.2K -$2.070M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
NIGHTFOOD HOLDINGS, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3885019
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
520 White Plains Road-Suite 500
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
13755589 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
95964484 shares
CY2022 dei Auditor Firm
AuditorFirmId
587
CY2022 dei Auditor Name
AuditorName
RBSM LLP
CY2022 dei Auditor Location
AuditorLocation
New York, NY
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
280877 usd
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1041899 usd
CY2022Q2 ngtf Net Allowance
NetAllowance
0 usd
CY2021Q2 ngtf Net Allowance
NetAllowance
0 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93674 usd
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
109589 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
331531 usd
CY2021Q2 us-gaap Inventory Net
InventoryNet
387736 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
137797 usd
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
33480 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
843879 usd
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1572704 usd
CY2022Q2 us-gaap Assets
Assets
843879 usd
CY2021Q2 us-gaap Assets
Assets
1572704 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
234152 usd
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
459703 usd
CY2021Q2 us-gaap Accrued Rent Current
AccruedRentCurrent
3000 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
344151 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
578303 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
462703 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q2 ngtf Preferred Stock B
PreferredStockB
3 usd
CY2021Q2 ngtf Preferred Stock B
PreferredStockB
5 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91814484 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91814484 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80707467 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80707467 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
91814 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
80707 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28275216 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26226159 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28101458 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25196871 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
265576 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1110001 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
843879 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1572704 usd
CY2022 us-gaap Revenues
Revenues
443538 usd
CY2021 us-gaap Revenues
Revenues
701246 usd
CY2022 ngtf Cost Of Product Sold
CostOfProductSold
486163 usd
CY2021 ngtf Cost Of Product Sold
CostOfProductSold
721777 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
596331 usd
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
588172 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
492713 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
479881 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
797666 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
1421045 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
2372873 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
3210875 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1929335 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-2509629 usd
CY2021 ngtf Gain On Accounts Payable Settlement
GainOnAccountsPayableSettlement
715075 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
1012 usd
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
177693 usd
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
48309 usd
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
102800 usd
CY2022 us-gaap Financing Interest Expense
FinancingInterestExpense
270210 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2100405 usd
CY2021 ngtf Gain On Debt Extinguishment Upon Refinancing
GainOnDebtExtinguishmentUponRefinancing
658080 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-853329 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
275423 usd
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
814769 usd
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
593942 usd
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
970195 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-2523277 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-3479824 usd
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
381310 usd
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
4085925 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2904587 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7565749 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87521595 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71090407 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-4481147 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
372253 usd
CY2021 ngtf Stock Issued During Period Value For Interest
StockIssuedDuringPeriodValueForInterest
184274 usd
CY2021 ngtf Issuance Of Common Stock For Debt Conversion
IssuanceOfCommonStockForDebtConversion
1433000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
613009 usd
CY2021 ngtf Fair Value Of Shares Issued Upon Debt Conversion
FairValueOfSharesIssuedUponDebtConversion
2100435 usd
CY2021 ngtf Preferred Stock B From Extinguishment Of Convertible Notes
PreferredStockBFromExtinguishmentOfConvertibleNotes
1500001 usd
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
15 shares
CY2021 ngtf Stock During Period Preferred Stock B Issued From Private Placement Net Of Financing Cost
StockDuringPeriodPreferredStockBIssuedFromPrivatePlacementNetOfFinancingCost
2868000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3479824 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1110001 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
214125 usd
CY2022 ngtf B Isued From Private Placement
BIsuedFromPrivatePlacement
335000 usd
CY2022 ngtf Preferred B Issued Financing Cost
PreferredBIssuedFinancingCost
-26800 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
931272 usd
CY2022 ngtf Stock Issued During Period Warrants Issued As Financing Cost
StockIssuedDuringPeriodWarrantsIssuedAsFinancingCost
170210 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
39045 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2523277 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
265576 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2523277 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3479824 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
214125 usd
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
372253 usd
CY2022 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
275423 usd
CY2021 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
917569 usd
CY2022 ngtf Warrants Issued For Services
WarrantsIssuedForServices
39045 usd
CY2021 ngtf Warrants Issued For Services
WarrantsIssuedForServices
613009 usd
CY2022 ngtf Warrant Issued For Financing Cost
WarrantIssuedForFinancingCost
-170210 usd
CY2021 ngtf Gain On Accounts Payable Settlement
GainOnAccountsPayableSettlement
715075 usd
CY2021 ngtf Loss On Extinguishment Of Debt Upon Note Conversion
LossOnExtinguishmentOfDebtUponNoteConversion
2100405 usd
CY2021 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
658080 usd
CY2021 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-853329 usd
CY2021 ngtf Stock Issued For Interest
StockIssuedForInterest
184274 usd
CY2022 us-gaap Noncash Contribution Expense
NoncashContributionExpense
15192 usd
CY2021 ngtf Allowance For Inventories
AllowanceForInventories
-24403 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15915 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48576 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-56205 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
136534 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
104317 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-152450 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-228551 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
93840 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6613 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2070030 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1439828 usd
CY2022 ngtf Proceeds From The Sale Of Stock
ProceedsFromTheSaleOfStock
-308200 usd
CY2021 ngtf Proceeds From The Sale Of Stock
ProceedsFromTheSaleOfStock
-2868000 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
984808 usd
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
720000 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
16000 usd
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1300000 usd
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3895 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1309008 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2284105 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-761022 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
844277 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1041899 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
197622 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
280877 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1041899 usd
CY2021 us-gaap Interest Paid Discontinued Operations
InterestPaidDiscontinuedOperations
1012 usd
CY2022 us-gaap Stock Issued1
StockIssued1
931272 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7950 usd
CY2022 ngtf Deemed Dividend Associated With Preferred Stock B
DeemedDividendAssociatedWithPreferredStockB
381310 usd
CY2021 ngtf Deemed Dividend Associated With Preferred Stock B
DeemedDividendAssociatedWithPreferredStockB
4085925 usd
CY2021 ngtf Initial Derivative Liability And Debt Discount Accounted
InitialDerivativeLiabilityAndDebtDiscountAccounted
512993 usd
CY2021 ngtf Non Cash Stock Issued For Conversion Of Debt
NonCashStockIssuedForConversionOfDebt
1433000 usd
CY2021 ngtf Derivative Liability Reclassed To Loss On Extinguishment Of Debt Upon Notes Conversion
DerivativeLiabilityReclassedToLossOnExtinguishmentOfDebtUponNotesConversion
2100405 usd
CY2021 ngtf Stock Issued For Interest1
StockIssuedForInterest1
184274 usd
CY2021 ngtf Trueup Adjustment In Debt Discount And Derivative Liability
TrueupAdjustmentInDebtDiscountAndDerivativeLiability
37360 usd
CY2021 ngtf Preferred Stock B From Extinguishment Of Convertible Note
PreferredStockBFromExtinguishmentOfConvertibleNote
1500001 usd
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of<br/> Business</b></span></td> <td style="width: 75%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nightfood Holdings, Inc. (the “Company”, “we”, “us” or “our”) is a Nevada Corporation organized October 16, 2013 to acquire all of the issued and outstanding shares of Nightfood, Inc., a New York Corporation from its sole shareholder, Sean Folkson.  All our operations are conducted by our Subsidiaries (Nightfood, Inc. and MJ Munchies, Inc.).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our corporate address is 520 White Plains Road – Suite 500, Tarrytown, New York 10591 and our telephone number is 888-888-6444. We maintain a web site at www.nightfood.com, along with several additional web properties. Any information that may appear on our web site should not be deemed to be a part of this report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s fiscal year end is June 30.</p></td></tr> </table>
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
212185 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
20000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
715075 usd
CY2021 ngtf Change In Derivative Liability During Period
ChangeInDerivativeLiabilityDuringPeriod
-853329 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></td> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used in the determination of depreciation and amortization, the valuation for non-cash issuances of common stock, and the website, income taxes and contingencies, valuing convertible notes for BCF (as defined below) and derivative liability, among others.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022 ngtf Description Of Beneficial Conversion Feature
DescriptionOfBeneficialConversionFeature
Beneficial Conversion Feature – Series B Preferred Stock (deemed dividend):   Each share of B Preferred has a liquidation preference of $1,000 and has no voting rights except as to matters pertaining to the rights and privileges of the B Preferred. Each share of B Preferred is convertible at the option of the holder thereof into (i) 5,000 shares of the Registrant’s common stock (one share for each $0.20 of liquidation preference) (the “Conversion Shares”) and (ii) 5,000 common stock purchase warrants, expiring April 16, 2026 (the “Warrants”). The Warrants carried an initial exercise price of $0.30 per share. Subsequent financing events resulted in adjustments to the exercise price of all warrants created from conversion of B Preferred from $.
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
1590638 usd
CY2019Q2 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2020-04-29
CY2019Q2 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2020-06-11
CY2019Q3 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2020-07-05
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 5%"> </td> <td style="vertical-align: top; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reclassification</b></span></td> <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may make certain reclassifications to prior period amounts to conform with the current year’s presentation.  Such reclassifications do not have a material effect on its consolidated statement of financial position, results of operations or cash flows.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022 us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 5%"> </td> <td style="vertical-align: top; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivative Financial Instruments</b></span></td> <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and then is revalued at each reporting date, with changes in fair value reported in the consolidated statement of operations. For stock based derivative financial instruments, fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 5%"> </td> <td style="vertical-align: top; width: 20%"> </td> <td style="vertical-align: top; width: 5%"> </td> <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once determined, derivative liabilities are adjusted to reflect fair value at the end of each reporting period. Any increase or decrease in the fair value from inception is made quarterly and appears in results of operations as a change in fair market value of derivative liabilities.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p>
CY2022Q2 ngtf Federal Depository Insurance Coverage
FederalDepositoryInsuranceCoverage
250000 usd
CY2019Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-09-24
CY2019Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-11-07
CY2019Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
150000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
596331 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
588172 usd
CY2022 ngtf Net Loss
NetLoss
2523277 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2070030 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1309008 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28101458 usd
CY2022 us-gaap Stockholders Equity Other
StockholdersEquityOther
256576 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></td> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions.  At various times during the year, the Company may exceed the federally insured limits.  To mitigate this risk, the Company places its cash deposits only with high credit quality institutions.  Management believes the risk of loss is minimal.  At June 30, 2022 and 2021 the Company did not have any uninsured cash deposits.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2019Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-12-31
CY2021 ngtf Description Of Receivables Concentration
DescriptionOfReceivablesConcentration
As of June 30, 2022, the Company had receivables due from six customers, one of who accounted for over 59% of the outstanding balance. One of the remaining five accounted for 13.5% of the outstanding balance and one accounted for 11% of the outstanding balance. As of June 30, 2021, the Company had receivables due from five customers, one of who accounted for over 73% of the outstanding balance. One of the remaining four accounted for 11.5% of the outstanding balance
CY2022 ngtf Percentage Of Operating Expense
PercentageOfOperatingExpense
0.10 pure
CY2021 ngtf Percentage Of Operating Expense
PercentageOfOperatingExpense
0.10 pure
CY2022Q2 us-gaap Inventory Gross
InventoryGross
331531 usd
CY2021Q2 us-gaap Inventory Gross
InventoryGross
387736 usd
CY2021 ngtf Initial Derivative Liability
InitialDerivativeLiability
512993 usd
CY2021 ngtf Trueup Adjustment In Debt Discount And Reconciliation Of Derivative Liability
TrueupAdjustmentInDebtDiscountAndReconciliationOfDerivativeLiability
37360 usd
CY2020Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
91880 usd
CY2020Q2 ngtf Maturity Date
MaturityDate
2021-04-30
CY2020Q2 ngtf Original Discount Percentage
OriginalDiscountPercentage
0.10 pure
CY2020Q2 us-gaap Interest Expense
InterestExpense
18700 usd
CY2020Q2 ngtf Maturity Date
MaturityDate
2021-06-23
CY2020Q3 ngtf Maturity Date
MaturityDate
2021-08-12
CY2021Q4 ngtf Share Price1
SharePrice1
20
CY2022 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
878260 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
165470 usd
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
338369 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
82625 usd
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
14760 usd
CY2022Q2 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
83436 usd
CY2021Q2 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
59010 usd
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
24403 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Deposit Assets
DepositAssets
134797 usd
CY2021Q2 us-gaap Deposit Assets
DepositAssets
33480 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
134797 usd
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
33480 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
170210 usd
CY2022 ngtf Sharebased Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate
SharebasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate
0.0125 pure
CY2022 ngtf Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumption Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionExpectedTerm1
P5Y
CY2022Q2 us-gaap Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate
LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate
1.4253 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q2 us-gaap Preferred Units Offering Costs
PreferredUnitsOfferingCosts
1000000 usd
CY2022 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
100000 usd
CY2020Q2 ngtf Debt Incentive Agreement
DebtIncentiveAgreement
947260 usd
CY2020Q4 us-gaap Cash
Cash
166224 usd
CY2020Q2 us-gaap Liabilities
Liabilities
947260 usd
CY2021Q2 us-gaap Cash
Cash
20000 usd
CY2022Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
715075 usd
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
947260 usd
CY2021Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
3000 usd
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3000 usd
CY2018Q2 us-gaap Convertible Debt
ConvertibleDebt
225000 usd
CY2018Q2 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2019-04-30
CY2018Q2 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.60 pure
CY2020 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
4098 usd
CY2020Q2 ngtf Conversion Loss
ConversionLoss
36242 usd
CY2022 us-gaap Legal Fees
LegalFees
15192 usd
CY2022 ngtf Amortization Related To Debt Discount Expense
AmortizationRelatedToDebtDiscountExpense
275423 usd
CY2021 ngtf Amortization Related To Debt Discount Expense
AmortizationRelatedToDebtDiscountExpense
814769 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
742807 usd
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 usd
CY2022 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
48309 usd
CY2021 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
177693 usd
CY2021 ngtf Notes Retired Due To Refinancing
NotesRetiredDueToRefinancing
-1287662 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1300000 usd
CY2022Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
5000 shares
CY2022Q2 ngtf Warrants
warrants
5000 shares
CY2021Q2 ngtf Debt Principal
DebtPrincipal
2325200 usd
CY2021 us-gaap Interest Paid
InterestPaid
186014 usd
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2511214 usd
CY2021Q2 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
1287662 usd
CY2021Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
340795 usd
CY2021Q2 us-gaap Escrow Deposit
EscrowDeposit
1300000 usd
CY2021 ngtf Gain On Extinguishment Of Debt Upon Refinancing
GainOnExtinguishmentOfDebtUponRefinancing
658080 usd
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2100435 usd
CY2021 ngtf Gain On Debt Extinguishment Upon Refinancing
GainOnDebtExtinguishmentUponRefinancing
658080 usd
CY2021 ngtf Loss On Extinguishment Debt
LossOnExtinguishmentDebt
1442325 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91814484 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91814484 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80707467 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80707467 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
214125 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1600000 shares
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16000 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
372253 usd
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
17249577 shares
CY2021 ngtf Principal Amount
PrincipalAmount
1433000 usd
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
184274 usd
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
3717709 usd
CY2022 ngtf Loss On Fair Value
LossOnFairValue
0 usd
CY2021 ngtf Loss On Fair Value
LossOnFairValue
2100435 usd
CY2021 ngtf Description Of Financing Activities
DescriptionOfFinancingActivities
These proceeds were used for operating capital. The Series B stock meets the criteria for equity classification and is accounted for as equity transactions. Specifically, among other factors, this qualifies as equity because redemption is not invoked at the option of the holder and the Series B stock does not have to be redeemed on a specified date.
CY2022Q2 ngtf Issuance Of Total Shares
IssuanceOfTotalShares
335 shares
CY2021Q2 ngtf Issuance Of Total Shares
IssuanceOfTotalShares
4665 shares
CY2022 ngtf Transaction Amount
TransactionAmount
4085925 usd
CY2022 ngtf Vendors Issuing Warrants
VendorsIssuingWarrants
500000 shares
CY2022 ngtf Strike Price
StrikePrice
0.5
CY2022Q2 us-gaap Long Term Debt Term
LongTermDebtTerm
P5Y
CY2022 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Fair Value Volatility Rate
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherFairValueVolatilityRate
1.0793 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0029 pure
CY2021Q1 ngtf Warrants Acquire Shares
WarrantsAcquireShares
400000 shares
CY2021Q1 ngtf Strike Price
StrikePrice
30
CY2021Q1 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Fair Value Volatility Rate
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherFairValueVolatilityRate
1.0793 pure
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.005 pure
CY2022 ngtf Warrant Description
WarrantDescription
01. The warrants included a provision for cashless exercise and carried a 5 years term. The Company valued these warrants using the Black Scholes model utilizing a 107.93% ~ 156.11% volatility and a risk-free rate of 0.45% ~ 0.85%. All of such warrants were exercised during the fiscal year ended June 30, 2022 for cash proceeds of $16,000 Additionally, the Placement Agent received 2,250,000 success warrants at a strike price of $0.20 and 2,250,000 success warrants at a strike price of $0.30, with expiration in 5 years. The Company recorded the retainer warrants into consulting expenses and recognized value of success warrants as part of financing costs issued as an equity instrument with the fair value debited to additional paid in capital. There is no accounting effect for these transactions associated with these success warrants.
CY2022Q2 ngtf Converted Shares
ConvertedShares
1740 shares
CY2022Q2 ngtf Common Stock Shares
CommonStockShares
8700000 shares
CY2022 ngtf Exercise Price
ExercisePrice
2919
CY2022 ngtf Warrants Issued
WarrantsIssued
878260 shares
CY2022 ngtf Initial Exercise Price
InitialExercisePrice
25
CY2022 ngtf Convertible Notedescription
ConvertibleNotedescription
For example, as a result of the convertible note financing, we completed in December 2021 which would allow the new noteholders to convert their debt to shares of common stock at an exercise price of $.20/share, some of the $.30 warrants outstanding in the table below had their exercise price reduced from $.30 to $.2952 which were further adjusted to $.2919 prior to June 30, 2022. This reduction of less than one penny in the exercise price of the 25,000,000 warrants associated with our Class B Preferred stock would result in proceeds to the Company of $7,297,500 rather than $7,500,000 should all those cash warrants be exercised. The result of the warrant exercise price downward adjustment on modification date was treated as a deemed dividend and fully amortized on the transaction date, and the Company recorded $91,375 to additional paid in capital and retained earnings on the Company’s balance sheets.
CY2022 ngtf Aggregate Intrinsic Value
AggregateIntrinsicValue
11650 usd
CY2021 ngtf Aggregate Intrinsic Value
AggregateIntrinsicValue
613009 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
-0.119 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.071 pure
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8050000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
14078260 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
950000 shares
CY2022 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
1600000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19578260 shares
CY2022 ngtf Related Party Transaction Agreement Terms
RelatedPartyTransactionAgreementTerms
P1Y
CY2022 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
the Company hitting certain revenue milestones of $1,000,000 in a quarter and $3,000,000 in a quarter. Achieving those milestones would earn Mr. Folkson warrants with a $.50 and $1 strike price which would need to be exercised within 90 days of the respective quarterly or annual filing.
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
400000 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
30
CY2022 ngtf Consulting Fee
ConsultingFee
6000 usd
CY2021 ngtf Consulting Fee
ConsultingFee
6000 usd
CY2022 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
72000 usd
CY2021 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
72000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
0 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
3000 usd
CY2017Q4 ngtf Cost Of Per Warrant
CostOfPerWarrant
15
CY2017Q4 ngtf Warrants Additional Shares
WarrantsAdditionalShares
80000 shares
CY2017Q4 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
20
CY2017Q4 ngtf Consulting Fee
ConsultingFee
12000 usd
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
400000 shares
CY2019Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.3
CY2019Q4 us-gaap Product Liability Accrual Component Amount
ProductLiabilityAccrualComponentAmount
120000 usd
CY2022 ngtf Price Per Share
PricePerShare
50
CY2022 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
1
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.065 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.07 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.264 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.209 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2573365 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1958304 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2573365 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1958304 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12391173 usd
CY2022Q2 ngtf Net Operating Loss Carryforwards
NetOperatingLossCarryforwards
2614000 usd
CY2022 ngtf Operating Loss Carry Forwards Expiration Period Description
OperatingLossCarryForwardsExpirationPeriodDescription
expire between 2031 and 2037
CY2022 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0.80 pure
CY2022Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
655182 usd
CY2022 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Under section 382, should the Company experience a more than 50% change in its ownership over a 3 year period, the Company would be limited based on a formula as defined in the IRC to the amount per year it could utilize in that year of the net operating loss carryforwards.
CY2022 ngtf Convertible Preferred Equitydeseription
ConvertiblePreferredEquitydeseription
269 and 4,665 of the Company’s Class B Preferred Stock, which is convertible into 16,345,000 and 23,325,000 shares of common stock, is not included in the computation for the fiscal year ended June 30, 2022 and 2021, respectively. Such conversions would also create 16,345,000 and 23,325,000 cash warrants with an exercise price of approximately $.29. During the fiscal year ended June 30, 2022, 1,740 shares of Series B Stock had exercised conversions, so 8,700,000 related warrants were issued and outstanding as of June 30, 2022.
CY2022 ngtf Warrants Exercisable Shares
warrantsExercisableShares
19578260 shares
CY2021 ngtf Warrants Exercisable Shares
warrantsExercisableShares
8050000 shares
CY2022 ngtf Numerator Basic And Diluted Loss Per Share Net Loss
NumeratorBasicAndDilutedLossPerShareNetLoss
2523277 usd
CY2021 ngtf Numerator Basic And Diluted Loss Per Share Net Loss
NumeratorBasicAndDilutedLossPerShareNetLoss
-3479824 usd
CY2022 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
381310 usd
CY2021 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
4085925 usd
CY2022 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
2904587 usd
CY2021 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-7565749 usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87521595 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71090407 shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
usd
CY2022 us-gaap Interest Paid Discontinued Operations
InterestPaidDiscontinuedOperations
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Stock Issued1
StockIssued1
usd
CY2022 ngtf Initial Derivative Liability And Debt Discount Accounted
InitialDerivativeLiabilityAndDebtDiscountAccounted
usd
CY2022 ngtf Non Cash Stock Issued For Conversion Of Debt
NonCashStockIssuedForConversionOfDebt
usd
CY2022 ngtf Derivative Liability Reclassed To Loss On Extinguishment Of Debt Upon Notes Conversion
DerivativeLiabilityReclassedToLossOnExtinguishmentOfDebtUponNotesConversion
usd
CY2021Q2 us-gaap Shares Issued
SharesIssued
164653 shares
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
213
CY2022Q2 us-gaap Accrued Rent Current
AccruedRentCurrent
usd
CY2021Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2021 us-gaap Financing Interest Expense
FinancingInterestExpense
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 ngtf Warrant Issued For Financing Cost
WarrantIssuedForFinancingCost
usd
CY2022 ngtf Gain On Accounts Payable Settlement
GainOnAccountsPayableSettlement
usd
CY2022 ngtf Loss On Extinguishment Of Debt Upon Note Conversion
LossOnExtinguishmentOfDebtUponNoteConversion
usd
CY2022 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
CY2022 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
CY2022 ngtf Stock Issued For Interest
StockIssuedForInterest
usd
CY2021 us-gaap Noncash Contribution Expense
NoncashContributionExpense
usd
CY2022 ngtf Allowance For Inventories
AllowanceForInventories
usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022 ngtf Stock Issued For Interest1
StockIssuedForInterest1
usd
CY2022 ngtf Trueup Adjustment In Debt Discount And Derivative Liability
TrueupAdjustmentInDebtDiscountAndDerivativeLiability
usd
CY2022 ngtf Preferred Stock B From Extinguishment Of Convertible Note
PreferredStockBFromExtinguishmentOfConvertibleNote
usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
CY2022Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
usd
CY2021Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
usd
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
usd
CY2021Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
usd
CY2022Q2 ngtf Derivative Liability
DerivativeLiability
usd
CY2017Q4 ngtf Related Party Transaction Agreement Terms
RelatedPartyTransactionAgreementTerms
P3Y
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei City Area Code
CityAreaCode
888
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001593001
CY2022 dei Entity File Number
EntityFileNumber
000-55406
CY2022 dei Local Phone Number
LocalPhoneNumber
888-6444

Files In Submission

Name View Source Status
0001213900-22-059811-index-headers.html Edgar Link pending
0001213900-22-059811-index.html Edgar Link pending
0001213900-22-059811.txt Edgar Link pending
0001213900-22-059811-xbrl.zip Edgar Link pending
f10k2022ex31-1_nightfood.htm Edgar Link pending
f10k2022ex32-1_nightfood.htm Edgar Link pending
f10k2022_nightfoodhold.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_003a.jpg Edgar Link pending
image_003b.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
ngtf-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
ngtf-20220630_pre.xml Edgar Link unprocessable
ngtf-20220630_lab.xml Edgar Link unprocessable
ngtf-20220630_cal.xml Edgar Link unprocessable
ngtf-20220630_def.xml Edgar Link unprocessable
f10k2022_nightfoodhold_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable